Vinorelbine and estramustine in androgen-independent metastatic prostate cancer
Open Access
- 15 October 2000
- Vol. 89 (8) , 1824-1828
- https://doi.org/10.1002/1097-0142(20001015)89:8<1824::aid-cncr24>3.0.co;2-r
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Chemotherapy for advanced hormone refractory prostate cancerUrology, 1999
- Improvements in clinical benefit with vinorelbine in the treatment of hormone-refractory prostate cancer: A phase II trialAnnals of Oncology, 1999
- Vinblastine Versus Vinblastine Plus Oral Estramustine Phosphate for Patients With Hormone-Refractory Prostate Cancer: A Hoosier Oncology Group and Fox Chase Network Phase III TrialJournal of Clinical Oncology, 1999
- Phase II Study of Estramustine and Vinorelbine in Hormone-Refractory Prostate Carcinoma PatientsActa Oncologica, 1998
- Vinorelbine: an overviewCancer Treatment Reviews, 1996
- Estramustine Phosphate SodiumDrugs & Aging, 1995
- What is the maximum number of levels needed in pain intensity measurement?Pain, 1994
- Longitudinal Myotomy of Ileum for Bladder Replacement in DogsJournal of Urology, 1991
- The Treatment of Cancer PainNew England Journal of Medicine, 1985
- Clinical pharmacokinetics of estramustine phosphateUrology, 1984